PC001- A Study to Evaluate the Usability of PointCheck
Phase NA Completed
81 enrolled
Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer
Phase 1 Completed
59 enrolled
An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)
Completed
1,300 enrolled
Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Phase 1 Completed
18 enrolled 22 charts
Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Phase 3 Completed
393 enrolled 20 charts
A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
Phase 1 Terminated
6 enrolled
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Completed
4,626 enrolled
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Completed
361 enrolled
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
Phase 2 Completed
148 enrolled 45 charts
ADVANCE
Phase 3 Completed
406 enrolled 19 charts
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
Phase 3 Completed
237 enrolled 18 charts
Efficacy and Safety Study With MYL-1401H and Neulasta
Phase 3 Completed
193 enrolled
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Phase 3 Completed
398 enrolled
A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement
Phase 2 Completed
50 enrolled 39 charts
Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Phase 3 Completed
122 enrolled 19 charts
MB-6
Unknown
184 enrolled
A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Phase 1/2 Completed
15 enrolled
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
Phase 2 Completed
80 enrolled
FENSY
Phase 2 Unknown
120 enrolled
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome
Withdrawn
Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Phase 2 Completed
232 enrolled 19 charts
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase 2 Completed
163 enrolled
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Phase 2 Completed
80 enrolled
A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.
Phase 2 Completed
138 enrolled
Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
Phase 3 Unknown
120 enrolled
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Phase 3 Completed
847 enrolled 21 charts
Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer
Phase 1 Unknown
30 enrolled
Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients
Phase 1 Completed
24 enrolled
PROTECT-1
Phase 3 Completed
316 enrolled 20 charts
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
Phase 4 Completed
75 enrolled 14 charts
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
Phase 3 Completed
602 enrolled
Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
Phase 2 Completed
107 enrolled
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Phase 2 Completed
60 enrolled 17 charts
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Phase 3 Completed
135 enrolled 18 charts
Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
Phase 2 Completed
23 enrolled
Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers
Phase 1 Completed
36 enrolled
Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia
Phase 1 Completed
29 enrolled
PIONEER
Phase 3 Completed
218 enrolled 15 charts
Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
Completed
438 enrolled
A Phase II Study Comparing Pegylated rhG-CSF(HHPG-19K) and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
Phase 2 Completed
182 enrolled
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma
Phase 2 Completed
77 enrolled
The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants
Completed
203 enrolled 14 charts
A Study of Empirical Antifungal Therapy With Itraconazole
Completed
138 enrolled
A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
Phase 3 Completed
330 enrolled
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
Phase 3 Unknown
150 enrolled
A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Phase 1 Withdrawn
A Study of Ceftobiprole in Patients With Fever and Neutropenia.
Phase 3 Terminated
2 enrolled 4 charts
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Phase 1 Withdrawn
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
Phase 4 Completed
852 enrolled
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
Phase 2 Completed
44 enrolled